|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-11-22
|
|
pubmed:abstractText |
Tricyclic antidepressants (TCA) were used to treat nocturnal enuresis (NE) for decades of years although their real mechanisms are unknown. Recently, some case studies demonstrated the efficacy of selective serotonin reuptake inhibitors (SSRI) in the treatment of NE. Both TCA and SSRI have similar influences on serotonin transmission. This study was aimed at evaluating whether 5-hydroxytryptamine receptor 2A (5HTR2A) gene is associated with NE.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1098-2825
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
371-5
|
|
pubmed:meshHeading |
pubmed-meshheading:21089166-Child,
pubmed-meshheading:21089166-Constipation,
pubmed-meshheading:21089166-Diurnal Enuresis,
pubmed-meshheading:21089166-Female,
pubmed-meshheading:21089166-Gene Frequency,
pubmed-meshheading:21089166-Genetic Association Studies,
pubmed-meshheading:21089166-Humans,
pubmed-meshheading:21089166-Male,
pubmed-meshheading:21089166-Nocturnal Enuresis,
pubmed-meshheading:21089166-Phenotype,
pubmed-meshheading:21089166-Polymorphism, Single Nucleotide,
pubmed-meshheading:21089166-Receptor, Serotonin, 5-HT2A,
pubmed-meshheading:21089166-Sleep Arousal Disorders,
pubmed-meshheading:21089166-Taiwan
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Rs 6313 polymorphism in 5-hydroxytryptamine receptor 2A gene association with polysymptomatic primary nocturnal enuresis.
|
|
pubmed:affiliation |
Department of Pediatric, China Medical University Hospital, Taichung, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
